Article: SMITHKLINE BEECHAM: Bactroban Nasal to decrease risk of S. aureus nosocomial infections in patients.

M2 PRESSWIRE-23 April 1999-SMITHKLINE BEECHAM: SmithKline Beecham's Bactroban Nasal shown to decrease risk of S. aureus nosocomial infections in surgical patients (C)1994-99 M2 COMMUNICATIONS LTD

RDATE:190499

* New Study Suggests Role for Prophylaxis in Reducing Incidence of Life-Threatening and Costly Infections

SAN FRANCISCO, CA -- The pre-operative use of Bactroban Nasal (mupirocin calcium ointment, 2%, SmithKline Beecham), a broad-spectrum, topical antibiotic, significantly decreases the risk of Staphylococcus aureus (S. aureus) nosocomial infections among surgical patients, according to a new study reported today at the annual meeting of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!